Controversies in Management of Localized Prostate Cancer: Before and After Radical Local Therapy
Authors:
Open Access
- 1 January 2024
- journal article
- review article
- Published by Medknow in UroCancer Clinics of India
- Vol. 2 (1) , 14-16
Abstract
Summary: The therapeutic world of prostate cancer has evolved a lot in the last decade. Initially, we have only androgen deprivation therapies, earlier generation androgen receptor pathway inhibitor (ARPI), and chemotherapy. Now, we have multiple other options, and also there are ample data in all the spaces of its management. However, some areas need discussion, as controversies exist. In this review, we would like to throw some light on such controversial real in dealing with the biochemical recurrence after radical local therapy (RLT) and neoadjuvant treatment before RLT. We envisage to clear the cloud as per the existing literature.Keywords
This publication has 21 references indexed in Scilit:
- ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate CancerEuropean Urology, 2022
- Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate CancerJAMA Oncology, 2020
- Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional StudyEuropean Urology, 2019
- External Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European CohortEuropean Urology, 2019
- Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic ReviewEuropean Urology, 2019
- External Beam Re-Irradiation of Locally Recurrent Prostate Cancer with FFF-VMATInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2018
- Salvage reirradiation for local failure of prostate cancer after curative radiation therapy: Association of rectal toxicity with dose distribution and normal-tissue complication probability modelsAdvances in Radiation Oncology, 2018
- Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy—What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?Journal of Urology, 2015
- Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Multi-institutional CollaborationEuropean Urology, 2011
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006